Usted buscó: rrapportat (Maltés - Inglés)

il-perjodu rrapportat:
reported period:

Ġie rrapportat l-isturdament.
dizziness has been reported.

l-rep jiġi rrapportat lis-superviżur.
the rep is reported to the supervisor.

Ġie rrapportat ukoll raxx tal- ġilda.
skin rash has also been reported.

fi 43 pazjent, ġie rrapportat mard stabbli.
in 43 patients stable disease was reported.

progress inizjali hu rrapportat f’it u lv.
initial progress is reported in it and lv.

l-ebda każ ta’ doża eċċessiva ma ġie rrapportat.
no case of overdose has been reported.

Ġie rrapportat każ ta’ indeboliment renali bl-eżinofilja.
a case of renal failure with eosinophilia has been reported.

ebda każ ma ġie rrapportat f’pazjenti fil-fergħa fac.
no cases were reported in patients in fac.

ir-riżultat analitiku għandu jiġi rrapportat, korrett jew le.
the analytical result shall be reported corrected or uncorrected.

ma ġie rrapportat l-ebda każ ta’ doża eċċessiva għal optaflu.
no case of overdose has been reported for optaflu.

omeprazole ġie rrapportat li jinteraġixxi ma’ xi inibituri tal-protease.
omeprazole has been reported to interact with some protease inhibitors.

ebda disturb tat-tirojde ta’ grad 3–5 ma ġie rrapportat.
no grade 3-5 thyroid disorders were reported.

is-self il-ġdid huwa rrapportat ukoll skond id-daqs tiegħu.
new loans are also reported according to their size.

raxx ħafif għal moderat ġie rrapportat bil-komponenti individwali ta’ atripla.
mild-to-moderate rash has been reported with the individual components of atripla.

Ġie rrapportat ħass ħażin xi kultant akkompanjat b’rogħda jew b’ebusija.
fainting, sometimes accompanied by shaking or stiffening, has been reported.

sindromu fatali ta’ guillain-barré ġie rrapportat fil-provi kliniċi.
fatal guillain- barré syndrome has been reported in clinical trials.

madankollu sal-lum, ma ġie rrapportat l-ebda effett ta’ malformazzjoni partikolari.
however, to date, no particular malformative effect has been reported.

ebda każ ta’ reazzjonijiet serji tal-ġilda ma ġie rrapportat b’eslicarbazepine acetate.
no cases of serious cutaneous reactions have been reported with eslicarbazepine acetate.

emboliżmu pulmonari fatali ġie rrapportat f’pazjent wieħed (0.3%) li rċieva axitinib.
fatal pulmonary embolism was reported in one patient (0.3%) receiving axitinib.